Proin 50 label

Proin 50

Proin 50 Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

Not for human use. Keep out of reach of children. Consult a physician in case of accidental ingestion by humans.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

PROIN is indicated for the control of urinary incontinence due to urethral sphincter hypotonus in dogs.

History

There is currently no drug history available for this drug.

Other Information

Description: PROIN (phenylpropanolamine hydrochloride) is a sympathomimetic amine closely related to ephedrine.

Phenylpropanolamine hydrochloride (PPA) is the nonproprietary designation for benzenemethanol,α – (1-aminoethyl) – hydrochloride, (R*,S*) – , (± ).

The empirical formula is C9H13NO• HCl and the molecular weight is 187.67. It is a white crystalline compound having a slight aromatic odor.

PPA is freely soluble in water and alcohol but is practically insoluble in ether, benzene and chloroform. The chemical structure of phenylpropanolamine hydrochloride is:


Phenylpropanolamine Molecular Structure


Proin 50 Manufacturers

  • Pegasus Laboratories, Inc.
    Proin 50 | Pegasus Laboratories, Inc.
    No Recall

    Proin 50 | Pegasus Laboratories, Inc.

    Proin 50 | Pegasus Laboratories, Inc.

    The total recommended dosage for oral administration is 2 mg/kg (0.91 mg/lb) of body weight twice daily.  PROIN is scored and dosage should be calculated in half-tablet increments.